Literature DB >> 20336465

Three distinct episodes of GBS septicemia in a healthy newborn during the first month of life.

Hanna Soukka1, Kaisu Rantakokko-Jalava, Susanna Vähäkuopus, Olli Ruuskanen.   

Abstract

In neonates, recurrent group B streptococcal infection is uncommon, and two relapses are extremely rare. We report a case of three distinct episodes of Streptococcus agalactiae bacteremia in a healthy full-term infant over a 4-week period. The newborn had no apparent predisposing condition or infectious focus, and the recurrences occurred after adequate antimicrobial treatment, the second occurring after withdrawal of colonized breast milk. Finally, oral rifampin was combined to his antibiotic regimen, his colonization cultures turned negative, and no further relapses have occurred during the 11-month follow-up. Conclusion In this report, we describe a newborn with two exceptionally rapid recurrences of group B streptococcal septicemias, and who was successfully treated with combining rifampin to the antibiotic regimen.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20336465     DOI: 10.1007/s00431-010-1187-6

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  11 in total

1.  [Group B streptococcal infection with 2 recurrences in a newborn].

Authors:  M Lalande; H Marchandin; L Enaud; C Carrière; M Rodière; J Astruc
Journal:  Arch Pediatr       Date:  2002-01       Impact factor: 1.180

2.  Infant with two relapses of group B streptococcal sepsis documented by DNA restriction enzyme analysis.

Authors:  D W Denning; M Bressack; N J Troup; L S Tompkins
Journal:  Pediatr Infect Dis J       Date:  1988-10       Impact factor: 2.129

3.  Late-onset and recurrent neonatal Group B streptococcal disease associated with breast-milk transmission.

Authors:  Michael Kotiw; Gwang W Zhang; Grant Daggard; Elizabeth Reiss-Levy; John W Tapsall; Andrew Numa
Journal:  Pediatr Dev Pathol       Date:  2003-04-14

4.  Multiple group B streptococcal infections in a premature infant: eradication of nasal colonization with rifampin.

Authors:  D D Millard; M E Bussey; S T Shulman; R Yogev
Journal:  Am J Dis Child       Date:  1985-10

5.  In vitro activity of penicillin and rifampin against group B streptococci.

Authors:  M Maduri-Traczewski; E G Szymczak; D A Goldmann
Journal:  Rev Infect Dis       Date:  1983 Jul-Aug

6.  Recurrent group B streptococcal disease in infants: Who should receive rifampin?

Authors:  J T Atkins; G P Heresi; T M Coque; C J Baker
Journal:  J Pediatr       Date:  1998-03       Impact factor: 4.406

7.  Failure of rifampin to eradicate group B streptococcal colonization in infants.

Authors:  M Fernandez; M A Rench; E A Albanyan; M S Edwards; C J Baker
Journal:  Pediatr Infect Dis J       Date:  2001-04       Impact factor: 2.129

Review 8.  Recurrent group B streptococcal infections in infants: clinical and microbiologic aspects.

Authors:  P A Green; K V Singh; B E Murray; C J Baker
Journal:  J Pediatr       Date:  1994-12       Impact factor: 4.406

9.  Infected breast milk associated with late-onset and recurrent group B streptococcal infection in neonatal twins: a genetic analysis.

Authors:  Arnaud Gagneur; Geneviève Héry-Arnaud; Séverine Croly-Labourdette; Gisèle Gremmo-Feger; Sophie Vallet; Jacques Sizun; Roland Quentin; Didier Tandé
Journal:  Eur J Pediatr       Date:  2008-12-16       Impact factor: 3.183

10.  Acute bacterial, nonnecrotizing cellulitis in Finland: microbiological findings.

Authors:  Tuula Siljander; Matti Karppelin; Susanna Vähäkuopus; Jaana Syrjänen; Maija Toropainen; Juha Kere; Risto Vuento; Tapio Jussila; Jaana Vuopio-Varkila
Journal:  Clin Infect Dis       Date:  2008-03-15       Impact factor: 9.079

View more
  2 in total

1.  Late-onset group B streptococcus infections and severe bronchopulmonary dysplasia in an extremely preterm born infant.

Authors:  Raymond Suffolk; Lone Agertoft; Malene Johansen; Gitte Zachariassen
Journal:  BMJ Case Rep       Date:  2019-07-26

2.  Bacteremia in Early Infancy: Etiology and Management.

Authors:  Joseph B Cantey; Amanda C Farris; Sarah M McCormick
Journal:  Curr Infect Dis Rep       Date:  2016-01       Impact factor: 3.725

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.